메뉴 건너뛰기




Volumn 7, Issue 6, 2011, Pages 665-666

Psychosis in the context of sodium oxybate therapy

Author keywords

Narcolepsy; Psychoses substance induced; Sodium oxybate; Substance withdrawal syndrome

Indexed keywords

LORAZEPAM; OXYBATE SODIUM;

EID: 84855671572     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.1478     Document Type: Article
Times cited : (15)

References (8)
  • 1
    • 3042549688 scopus 로고    scopus 로고
    • Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: A review
    • DOI 10.1016/j.drugalcdep.2004.01.012, PII S0376871604000389
    • McDonough M, Kennedy N, Glasper A, Bearn J. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review. Drug Alcohol Depend 2004;75:3-9. (Pubitemid 38844572)
    • (2004) Drug and Alcohol Dependence , vol.75 , Issue.1 , pp. 3-9
    • McDonough, M.1    Kennedy, N.2    Glasper, A.3    Bearn, J.4
  • 2
    • 34547098612 scopus 로고    scopus 로고
    • Experiences of gamma hydroxybutyrate (GHB) ingestion: A focus group study
    • Barker JC, Harris SL, Dyer JE. Experiences of gamma hydroxybutyrate (GHB) ingestion: a focus group study. J Psychoactive Drugs 2007;39:115-29. (Pubitemid 47105694)
    • (2007) Journal of Psychoactive Drugs , vol.39 , Issue.2 , pp. 115-129
    • Barker, J.C.1    Harris, S.L.2    Dyer, J.E.3
  • 3
    • 55349104474 scopus 로고    scopus 로고
    • Gamma hydroxybutyrate: An ethnographic study of recreational use and abuse
    • Lee SJ, Levounis P. Gamma hydroxybutyrate: an ethnographic study of recreational use and abuse. J Psychoactive Drugs 2008;40:245-53.
    • (2008) J Psychoactive Drugs , vol.40 , pp. 245-253
    • Lee, S.J.1    Levounis, P.2
  • 4
    • 43349158928 scopus 로고    scopus 로고
    • Sodium oxybate: Efficacy, safety and tolerability in the treatment of narcolepsy with or without cataplexy
    • DOI 10.1358/dot.2008.44.3.1162240
    • Owen RT. Sodium oxybate: efficacy, safety and tolerability in the treatment of narcolepsy with or without cataplexy. Drugs Today (Barc) 2008;44:197-204. (Pubitemid 351669106)
    • (2008) Drugs of Today , vol.44 , Issue.3 , pp. 197-204
    • Owen, R.T.1
  • 5
    • 70349092220 scopus 로고    scopus 로고
    • Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): Abuse, misuse, dependence, and diversion
    • Wang YG, Swick TJ, Carter LP, Thorpy MJ, Benowitz NL. Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion. J Clin Sleep Med 2009;5:365-71.
    • (2009) J Clin Sleep Med , vol.5 , pp. 365-371
    • Wang, Y.G.1    Swick, T.J.2    Carter, L.P.3    Thorpy, M.J.4    Benowitz, N.L.5
  • 7
    • 77954680063 scopus 로고    scopus 로고
    • Rapid occurrence of depression following addition of sodium oxybate to modafinil
    • Rossetti AO, Heinzer RC, Tafti M, Buclin T. Rapid occurrence of depression following addition of sodium oxybate to modafinil. Sleep Med 2010;11:500-1.
    • (2010) Sleep Med , vol.11 , pp. 500-501
    • Rossetti, A.O.1    Heinzer, R.C.2    Tafti, M.3    Buclin, T.4
  • 8
    • 67349218983 scopus 로고    scopus 로고
    • Three deaths associated with use of Xyrem
    • Zvosec DL, Smith SW, Hall BJ. Three deaths associated with use of Xyrem. Sleep Med 2009;10:490-3.
    • (2009) Sleep Med , vol.10 , pp. 490-493
    • Zvosec, D.L.1    Smith, S.W.2    Hall, B.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.